|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Goodwill and intangible asset impairments | |||||
| Operating profit (loss) | |||||
| Nonoperating (expense) income: | |||||
| Other expense, net | |||||
| Interest expense, net | |||||
| Income (loss) before income taxes | |||||
| Income tax expense | |||||
| (Loss) Income from continuing operations, net of tax | |||||
| Income from discontinued operations, net of tax (Note 3) | |||||
| Net income (loss) | |||||
| Earnings (loss) per share: | |||||
| (Loss) earnings from continuing operations - basic (in USD per share) | |||||
| (Loss) earnings from continuing operations - diluted (in USD per share) | |||||
| Earnings from discontinued operations - basic (in USD per share) | |||||
| Earnings from discontinued operations - diluted (in USD per share) | |||||
| Earnings (Loss) - basic (in USD per share) | |||||
| Earnings (Loss) - diluted (in USD per share) | |||||
| Average common stock and common equivalent shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...
